About Robert Hadfield
Robert Hadfield is an executive officer at Newleos Therapeutics.
Robert Hadfield reports to the SEC as an officer of 2 public companies: Alaunos Therapeutics (TCRT) and Decoy Therapeutics (DCOY).
Robert Hadfield first appears on SEC filings in 2015.
Experience
This experience comes from SEC filings. The years are when the filings name Robert Hadfield in the role, so the role may have started earlier or lasted longer.
AI
Alaunos Therapeutics, Inc.
Chief Legal Officer and Sec
2018 – 2021 · Public company (TCRT)
DI
Decoy Therapeutics Inc.
General Counsel & Secretary
2015 – 2017 · Public company (DCOY)
Key Colleagues at Startups
The people Robert Hadfield works with at each company, as listed on that company's latest Form D.
Newleos Therapeutics, Inc. · Form D, Feb 24, 2025
DD
David Donabedian
President and CEO, director
CW
Christoph Westphal
Director
MC
Ming Cheah
Director
RC
Raymond Camahort
Director
JM
John McCabe
Executive officer